Company Filing History:
Years Active: 2000
Title: The Innovative Mind of Scott Harold Rongey
Introduction
Scott Harold Rongey, an accomplished inventor based in San Diego, California, holds a significant patent in the field of biomedical engineering. With a focus on advancing medical diagnostics, Rongey's work has contributed to the development of more efficient assay devices, showcasing his expertise and innovative thinking.
Latest Patents
Rongey is credited with a patent for a "lysis chamber for use in an assay device." This inventive chamber is designed to produce lysis of cells in a sample fluid, such as whole blood. The unique chamber comprises a surface that comes into contact with the sample fluid upon placement into the assay device, and it features a lytic material immobilized on the surface. When the cells in the sample fluid come into contact with the lytic material, they are lysed, enabling the efficient analysis of critical substances. The chamber also has the capability to delimit a capillary space, and suitable lytic materials could include saponin or a detergent. This technology allows for the assay of important medical markers like cyclosporin or hemoglobin A1c using whole blood samples.
Career Highlights
Scott Harold Rongey is currently employed at Biosite Diagnostics, Inc., where he continues to innovate and contribute to the field of diagnostics. His work not only underscores his dedication to enhancing medical technology but also reflects his commitment to improving patient care through scientific advancement.
Collaborations
Throughout his career, Rongey has collaborated with notable professionals, including Kenneth Francis Buechler and Jason Christopher Briggs. These collaborations have fostered a rich environment for innovation, allowing for the exchange of ideas and expertise that have propelled advancements in assay device technology.
Conclusion
Scott Harold Rongey exemplifies the spirit of innovation in the medical field. His patent for the lysis chamber represents a significant contribution to diagnostic technology, making it easier to analyze critical health indicators from whole blood samples. Through his work at Biosite Diagnostics, Inc. and his collaborations with fellow innovators, Rongey continues to impact the biotechnology sector, paving the way for future advancements in medical diagnostics.